Webby, R.J. The practical longevity of stockpiled A(H5N1) influenza vaccine. Nat Med (2024)
Stockpiled A(H5N1) influenza vaccines made using viruses from the mid-2000s stimulate antibodies that cross-react with current strains, despite being separated by 20 years of viral evolution — supporting investment in vaccine stockpiling for pandemic preparedness.
See Also:
Latest articles in those days:
- Nonstructural Protein 1 of Influenza A (NS1A) Demonstrates Strain-Specific dsRNA Binding Capabilities 4 hours ago
- One-pot synthesized three-way junction based multiple strand displacement amplification for sensitive assay of H5N1 DNA 4 hours ago
- [preprint]The impact of influenza A H5N1 virus infection in dairy cows 6 hours ago
- Human Cases of Highly Pathogenic Avian Influenza A(H5N1) - California, September-December 2024 7 hours ago
- Immune history shapes human antibody responses to H5N1 influenza viruses 19 hours ago
[Go Top] [Close Window]